GeneBio and Proxeon Sign Agreement for Phenyx and ProteinCenter
News Oct 28, 2008
Financial terms of the agreement were not disclosed. Under the terms of the agreement, GeneBio's Phenyx will be integrated with Proxeon's ProteinCenter to provide proteomics scientists with a professional bioinformatics solution to significantly enhance the efficiency and effectiveness of analyzing and interpreting mass spectrometry data. The integration will be through direct links from Phenyx identifications to ProteinCenter and specific Phenyx exports loaded into ProteinCenter.
ProteinCenter, based on a consolidated, biologically annotated, protein sequence database derived from all major protein databases, enables filtering, protein grouping and statistical bioinformatic analysis of single, combined or comparison proteomics search results. Users benefit from faster, more confident data interpretation through one unique analytical tool. http://www.proxeon.com/productrange/data_interpretation/introduction/index.html
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio's renowned software platform for the identification and characterization of proteins and peptides from mass spectrometry data. The Phenyx platform is specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment via a customizable architecture and an innovative user-friendly interface. http://phenyx.vital-it.ch/pwi
"Phenyx is a well-established search engine used for protein identification within the proteomics community," said Morten Bern, Director of Bioinformatics for Proxeon. "ProteinCenter is used, to put identified proteins into a biological context within minutes - a process that can take months using conventional tools. The integration of Phenyx' results into ProteinCenter, rapidly providing highly accurate and reliable identification results, will be extremely valuable to our clients"
"We realize that customers can benefit significantly from tools that facilitate data analysis and interpretation downstream of protein identification," said Nasri Nahas, CEO of GeneBio. "The integration of Phenyx and ProteinCenter will provide a seamless solution that puts their data into a biological context and is far less time consuming. We look forward to a fruitful collaboration with Proxeon that will truly benefit the scientific community."
The collaboration extends to co-marketing activities; ProteinCenter will be distributed through Proxeon and GeneBio sales channels, while GeneBio will continue as the supplier of Phenyx.
Changing Lanes: Algorithm Helps AI Drive More Like HumansNews
For self-driving cars, algorithms for changing lanes are beset by one of two problems. Either, they rely on detailed statistical models of the driving environment, which are too complex to analyze on the fly; or they’re so simple that they can lead to impractically conservative decisions, such as never changing lanes at all. Now a new algorithm hopes to split the difference, allowing aggressive lane changes than the simple models do but relies only on immediate information about other vehicles’ directions and velocities to make decisions.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018